Board of Directors update

Posted on Nov 9, 2017

Oslo, Norway, November 9, 2017 – Prof. Kjetil Taskén, MD, PhD has notified PCI Biotech Holding ASA’s Nomination Committee and Board of Directors that he is not able to be a candidate for re-election as Director of PCI Biotech Holding ASA’s Board of Directors at the next ordinary general meeting, in May 2018. Prof. Taskén […]

PCI Biotech to present at BIO-Europe 2017

Posted on Nov 6, 2017

Oslo, Norway, November 6, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at BIO-Europe 2017 being held November 6-8, 2017 at the CityCube Berlin, Germany. On Tuesday, November 7, 2017 at 09:30am (CET), Mr. Gaël L’Hévéder, CBDO, will present an overview […]

Employee share option scheme

Posted on Oct 17, 2017

Oslo (Norway), 17 October 2017 – In accordance with the authorisation granted by the Annual General Meeting 29 May 2017, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 90,000 share options to key employees.  The share options are allotted to the newly hired Chief Medical Officer, Hans Olivecrona. Each share […]